SG11202101098YA - Cell production method - Google Patents
Cell production methodInfo
- Publication number
- SG11202101098YA SG11202101098YA SG11202101098YA SG11202101098YA SG11202101098YA SG 11202101098Y A SG11202101098Y A SG 11202101098YA SG 11202101098Y A SG11202101098Y A SG 11202101098YA SG 11202101098Y A SG11202101098Y A SG 11202101098YA SG 11202101098Y A SG11202101098Y A SG 11202101098YA
- Authority
- SG
- Singapore
- Prior art keywords
- production method
- cell production
- cell
- production
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0068—General culture methods using substrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/33—Insulin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/72—Transferases [EC 2.]
- C12N2501/727—Kinases (EC 2.7.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2513/00—3D culture
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018146650 | 2018-08-03 | ||
PCT/JP2019/030437 WO2020027316A1 (en) | 2018-08-03 | 2019-08-02 | Cell production method |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202101098YA true SG11202101098YA (en) | 2021-03-30 |
Family
ID=69230862
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202101098YA SG11202101098YA (en) | 2018-08-03 | 2019-08-02 | Cell production method |
Country Status (10)
Country | Link |
---|---|
US (1) | US20210292708A1 (en) |
EP (1) | EP3831931A4 (en) |
JP (1) | JP7370600B2 (en) |
CN (1) | CN112912490B (en) |
AU (1) | AU2019313964A1 (en) |
CA (1) | CA3108679A1 (en) |
IL (1) | IL280556A (en) |
SG (1) | SG11202101098YA (en) |
TW (1) | TW202014514A (en) |
WO (1) | WO2020027316A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3587560A4 (en) * | 2017-01-27 | 2020-12-16 | Kaneka Corporation | Endodermal cell mass, and method for producing any one of three primary germ layer cell mass from pluripotent cells |
EP4249587A1 (en) * | 2020-11-20 | 2023-09-27 | Orizuru Therapeutics, Inc. | Maturation agent |
CN114807013B (en) * | 2022-04-25 | 2023-11-17 | 宫念樵 | Method for differentiating peripheral blood stem cells into endoderm cells and application thereof |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL1610642T3 (en) | 2004-04-10 | 2007-01-31 | Henkel Kgaa | Hair roller |
US8048999B2 (en) | 2005-12-13 | 2011-11-01 | Kyoto University | Nuclear reprogramming factor |
US8278104B2 (en) | 2005-12-13 | 2012-10-02 | Kyoto University | Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2 |
US8741643B2 (en) * | 2006-04-28 | 2014-06-03 | Lifescan, Inc. | Differentiation of pluripotent stem cells to definitive endoderm lineage |
US7661738B2 (en) | 2006-11-28 | 2010-02-16 | Veritainer Corporation | Radiation detection unit for mounting a radiation sensor to a container crane |
JP2010523117A (en) | 2007-04-07 | 2010-07-15 | ホワイトヘッド・インスティテュート・フォー・バイオメディカル・リサーチ | Somatic cell reprogramming |
JP2010528622A (en) | 2007-05-30 | 2010-08-26 | ザ ジェネラル ホスピタル コーポレイション | Methods for generating pluripotent cells from somatic cells |
JP2008307007A (en) | 2007-06-15 | 2008-12-25 | Bayer Schering Pharma Ag | Human pluripotent stem cell induced from human tissue-originated undifferentiated stem cell after birth |
CA2693156C (en) | 2007-07-18 | 2018-03-06 | Alireza Rezania | Differentiation of human embryonic stem cells |
EP2356227B1 (en) | 2008-11-14 | 2018-03-28 | Viacyte, Inc. | Encapsulation of pancreatic cells derived from human pluripotent stem cells |
PL2611910T3 (en) | 2010-08-31 | 2018-06-29 | Janssen Biotech, Inc | Differentiation of human embryonic stem cells |
CA3212301A1 (en) * | 2013-02-06 | 2014-08-14 | Viacyte, Inc. | Cell compositions derived from dedifferentiated reprogrammed cells |
JP6232638B2 (en) | 2013-06-24 | 2017-11-22 | 国立研究開発法人医薬基盤・健康・栄養研究所 | Hepatic progenitor cell growth medium |
GB201317869D0 (en) * | 2013-10-09 | 2013-11-20 | Cambridge Entpr Ltd | In vitro production of foregut stem cells |
CA2957000C (en) | 2014-08-04 | 2023-08-01 | Takeda Pharmaceutical Company Limited | Method for proliferation of pancreatic progenitor cells |
JP7209619B2 (en) | 2016-07-28 | 2023-01-20 | エフ.ホフマン-ラ ロシュ アーゲー | Non-human primate induced pluripotent stem cell-derived hepatocytes and uses thereof |
JP6932947B2 (en) | 2017-03-02 | 2021-09-08 | コニカミノルタ株式会社 | Defective image occurrence prediction system and defective image occurrence prediction program |
BR112021004815A2 (en) * | 2018-09-19 | 2021-06-01 | Takeda Pharmaceutical Company Limited | insulin-producing cells, medicine, and, methods of producing insulin-producing cells, to generate pancreatic islet-like cells, to treat diabetes mellitus, to improve and/or maintain control of fasting and postprandial glucose levels in a patient and to reduce the risk of hypoglycaemia in a patient with diabetes mellitus |
-
2019
- 2019-08-02 WO PCT/JP2019/030437 patent/WO2020027316A1/en unknown
- 2019-08-02 US US17/265,364 patent/US20210292708A1/en active Pending
- 2019-08-02 CN CN201980050988.3A patent/CN112912490B/en active Active
- 2019-08-02 TW TW108127557A patent/TW202014514A/en unknown
- 2019-08-02 SG SG11202101098YA patent/SG11202101098YA/en unknown
- 2019-08-02 EP EP19845166.8A patent/EP3831931A4/en active Pending
- 2019-08-02 CA CA3108679A patent/CA3108679A1/en not_active Abandoned
- 2019-08-02 AU AU2019313964A patent/AU2019313964A1/en not_active Abandoned
- 2019-08-02 JP JP2020534768A patent/JP7370600B2/en active Active
-
2021
- 2021-02-01 IL IL280556A patent/IL280556A/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP7370600B2 (en) | 2023-10-30 |
TW202014514A (en) | 2020-04-16 |
EP3831931A4 (en) | 2022-05-18 |
IL280556A (en) | 2021-03-25 |
CA3108679A1 (en) | 2020-02-06 |
CN112912490B (en) | 2023-12-26 |
US20210292708A1 (en) | 2021-09-23 |
AU2019313964A1 (en) | 2021-03-18 |
WO2020027316A1 (en) | 2020-02-06 |
EP3831931A1 (en) | 2021-06-09 |
CN112912490A (en) | 2021-06-04 |
JPWO2020027316A1 (en) | 2021-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL276600A (en) | Methods for manufacturing t cells | |
IL276597A (en) | Method for producing low-antigenic cell | |
EP3312846A4 (en) | Solid electrolyte production method | |
EP3712967C0 (en) | Method for manufacturing solar cell | |
HUE064016T2 (en) | Method for producing lgps-based solid electrolyte | |
PL3809425T3 (en) | Lgps-based solid electrolyte and production method | |
HUE056390T2 (en) | Production method for solid electrolyte having li3ps4 | |
EP3312847A4 (en) | Solid electrolyte production method | |
GB201707143D0 (en) | Method for producing cells | |
HUE054696T2 (en) | Production method for lgps-based solid electrolyte | |
EP3518322A4 (en) | Production method for film-clad battery | |
EP3598462A4 (en) | Method for producing solid electrolyte | |
EP3751001C0 (en) | Ergothioneine production method | |
PL3699996T3 (en) | Production method for all-solid-state battery | |
IL280556A (en) | Cell production method | |
EP3778902A4 (en) | Cell production method | |
PL3942107T3 (en) | Production method | |
SG11202004021RA (en) | Production method for dihydroxyindoles | |
IL283085A (en) | Improved t cell manufacturing process | |
EP3663343A4 (en) | Porous-object production method | |
EP3587563A4 (en) | Nerve cell production method | |
EP3896155A4 (en) | Production method for genome-edited cells | |
EP3808839A4 (en) | Transformed cell production method | |
EP3780216A4 (en) | Battery production method | |
EP3719133A4 (en) | Method for producing neural cells |